Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy

During bone modeling, remodeling, and bone fracture repair, mesenchymal stem cells (MSCs) differentiate into chondrocyte or osteoblast to comply bone formation and regeneration. As multipotent stem cells, MSCs were used to treat bone diseases during the past several decades. However, most of these implications just focused on promoting MSC differentiation. Furthermore, cell migration is also a key issue for bone formation and bone diseases treatment. Abnormal MSC migration could cause different kinds of bone diseases, including osteoporosis. Additionally, for bone disease treatment, the migration of endogenous or exogenous MSCs to bone injury sites is required. Recently, researchers have paid more and more attention to two critical points. One is how to apply MSC migration to bone disease therapy. The other is how to enhance MSC migration to improve the therapeutic efficacy of bone diseases. Some considerable outcomes showed that enhancing MSC migration might be a novel trick for reversing bone loss and other bone diseases, such as osteoporosis, fracture, and osteoarthritis (OA). Although plenty of challenges need to be conquered, application of endogenous and exogenous MSC migration and developing different strategies to improve therapeutic efficacy through enhancing MSC migration to target tissue might be the trend in the future for bone disease treatment.

[1]  Y. Tabata,et al.  Biological apatite (BAp) crystallographic orientation and texture as a new index for assessing the microstructure and function of bone regenerated by tissue engineering. , 2012, Bone.

[2]  José Mauro Granjeiro,et al.  Cellular behavior as a dynamic field for exploring bone bioengineering: a closer look at cell-biomaterial interface. , 2014, Archives of biochemistry and biophysics.

[3]  C. Bünger,et al.  Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. , 1996, Bone.

[4]  G. Vunjak‐Novakovic,et al.  Extracellular matrix components and culture regimen selectively regulate cartilage formation by self-assembling human mesenchymal stem cells in vitro and in vivo , 2016, Stem Cell Research & Therapy.

[5]  Laura J Suggs,et al.  Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. , 2007, Tissue engineering.

[6]  Sanjay Kumar,et al.  Bone homing of mesenchymal stem cells by ectopic α4 integrin expression , 2007 .

[7]  T A Einhorn,et al.  The cell and molecular biology of fracture healing. , 1998, Clinical orthopaedics and related research.

[8]  Johnny Huard,et al.  VEGF Improves, Whereas sFlt1 Inhibits, BMP2‐Induced Bone Formation and Bone Healing Through Modulation of Angiogenesis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  C. Shao,et al.  Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression , 2010, The Journal of Immunology.

[10]  I. Sekiya,et al.  Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit , 2008, Cell and Tissue Research.

[11]  R. Gamelli,et al.  Mesenchymal Stem Cells Facilitate Fracture Repair in an Alcohol-Induced Impaired Healing Model , 2012, Journal of orthopaedic trauma.

[12]  P. Blanke,et al.  Functional regeneration of ischemic myocardium by transplanted cells overexpressing stromal cell-derived factor-1 (SDF-1): intramyocardial injection versus scaffold-based application. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  R. Bolli,et al.  Stromal Cell–Derived Factor-1&agr; Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell–Derived Factor-1&agr;–CXCR4 Axis , 2007 .

[14]  S. Xuan,et al.  Matrix IGF-1 regulates bone mass by activation of mTOR in mesenchymal stem cells , 2012, Nature Medicine.

[15]  Hiromu Ito.  Chemokines in mesenchymal stem cell therapy for bone repair: a novel concept of recruiting mesenchymal stem cells and the possible cell sources , 2011 .

[16]  K M Higgins,et al.  Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs. , 2001, Development.

[17]  I. Ko,et al.  Targeting mesenchymal stem cells to activated endothelial cells. , 2009, Biomaterials.

[18]  Y. Huang,et al.  TNF-α-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis , 2017, Cell Death and Disease.

[19]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[20]  J. Moraleda,et al.  Mesenchymal stem cells derived from dental tissues. , 2011, International endodontic journal.

[21]  Y. Qi,et al.  Combined Use of Mesenchymal Stromal Cell Sheet Transplantation and Local Injection of SDF-1 for Bone Repair in a Rat Nonunion Model , 2016, Cell transplantation.

[22]  L. Riley,et al.  Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis , 2013, Nature Medicine.

[23]  Pierre P. Eleniste,et al.  Osteoblast differentiation and migration are regulated by dynamin GTPase activity. , 2014, The international journal of biochemistry & cell biology.

[24]  Charles P. Lin,et al.  Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone , 2008, Nature Medicine.

[25]  K. Itoh,et al.  Changes in cell migration of mesenchymal cells during osteogenic differentiation , 2011, FEBS letters.

[26]  A. Bahrami,et al.  Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy , 2015, Cell biology international.

[27]  Yool-hee Yang,et al.  LL-37 stimulates the functions of adipose-derived stromal/stem cells via early growth response 1 and the MAPK pathway , 2016, Stem Cell Research & Therapy.

[28]  M. Farr,et al.  An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure , 2013, Circulation research.

[29]  D. Ornitz,et al.  Development of the endochondral skeleton. , 2013, Cold Spring Harbor perspectives in biology.

[30]  W. Tawackoli,et al.  PTH Induces Systemically Administered Mesenchymal Stem Cells to Migrate to and Regenerate Spine Injuries. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  Geert Carmeliet,et al.  Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. , 2010, Developmental cell.

[32]  K. Lam,et al.  Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass , 2012, Nature Medicine.

[33]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[34]  A. Ager,et al.  Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. , 2001, Blood.

[35]  D. Docheva,et al.  Mesenchymal stem cells from osteoporotic patients reveal reduced migration and invasion upon stimulation with BMP-2 or BMP-7. , 2014, Biochemical and biophysical research communications.

[36]  Hui Liu,et al.  Inhibition of SDF-1α/CXCR4 Signalling in Subchondral Bone Attenuates Post-Traumatic Osteoarthritis , 2016, International journal of molecular sciences.

[37]  Marcus J. Taylor,et al.  A Feedback Loop between Dynamin and Actin Recruitment during Clathrin-Mediated Endocytosis , 2012, PLoS biology.

[38]  R. Najafi,et al.  Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats , 2013, Expert opinion on biological therapy.

[39]  W. Rottbauer,et al.  GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair. , 2013, International journal of cardiology.

[40]  A. Montag,et al.  Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[41]  I. Ghiran,et al.  Human Bone Marrow Stromal Cells Express a Distinct Set of Biologically Functional Chemokine Receptors , 2006, Stem cells.

[42]  A. Rabie,et al.  The role of vascular endothelial growth factor in ossification , 2012, International Journal of Oral Science.

[43]  Yong Zhou,et al.  CXCL12 overexpression promotes the angiogenesis potential of periodontal ligament stem cells , 2017, Scientific Reports.

[44]  Yi Tang,et al.  TGF-β1-induced Migration of Bone Mesenchymal Stem Cells Couples Bone Resorption and Formation , 2009, Nature Medicine.

[45]  O. Lee,et al.  Restoration of Bone Mass and Strength in Glucocorticoid‐Treated Mice by Systemic Transplantation of CXCR4 and Cbfa‐1 Co‐Expressing Mesenchymal Stem Cells , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[46]  P. Giannoudis,et al.  The systemic influence of platelet-derived growth factors on bone marrow mesenchymal stem cells in fracture patients , 2015, BMC Medicine.

[47]  A. Schambach,et al.  Enhancement of BMP-2 induced bone regeneration by SDF-1α mediated stem cell recruitment. , 2013, Tissue engineering. Part A.

[48]  Sahar Mansour,et al.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.

[49]  L. Tsai,et al.  Mesenchymal Stem Cells Primed With Valproate and Lithium Robustly Migrate to Infarcted Regions and Facilitate Recovery in a Stroke Model , 2011, Stroke.

[50]  R. Ransohoff,et al.  CXCL12 and CXCR4 in bone marrow physiology , 2010, Expert review of hematology.

[51]  F. Pfeiffer,et al.  Six-dimensional real and reciprocal space small-angle X-ray scattering tomography , 2015, Nature.

[52]  F. Sellke,et al.  Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. , 2008, Current drug targets.

[53]  Fanxin Long,et al.  Building strong bones: molecular regulation of the osteoblast lineage , 2011, Nature Reviews Molecular Cell Biology.

[54]  George Kontakis,et al.  The influence of osteoporosis in femoral fracture healing time. , 2009, Injury.

[55]  E. Schwarz,et al.  Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. , 2009, Arthritis and rheumatism.

[56]  P. De Camilli,et al.  A Functional Link between Dynamin and the Actin Cytoskeleton at Podosomes , 2000, The Journal of cell biology.

[57]  D. Scadden,et al.  The stem-cell niche as an entity of action , 2006, Nature.

[58]  M. Hansen,et al.  Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor‐kappa B (RANK) Signaling , 2015, Journal of cellular physiology.

[59]  R. Zhao,et al.  Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. , 2007, Haematologica.

[60]  R. Béliveau,et al.  Hypoxia Promotes Murine Bone‐Marrow‐Derived Stromal Cell Migration and Tube Formation , 2003, Stem cells.

[61]  E. Mackie,et al.  Endochondral ossification: how cartilage is converted into bone in the developing skeleton. , 2008, The international journal of biochemistry & cell biology.

[62]  I. Sekiya,et al.  Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[63]  G. Blunn,et al.  Osteoporosis and ageing affects the migration of stem cells and this is ameliorated by transfection with CXCR4 , 2017, Bone & joint research.

[64]  G. Prestwich,et al.  Recruitment of endogenous stem cells for tissue repair. , 2008, Macromolecular bioscience.

[65]  M. Chua,et al.  Matrix metalloproteinase‐1 facilitates MSC migration via cleavage of IGF‐2/IGFBP2 complex , 2017, FEBS open bio.

[66]  D. Banerjee,et al.  Activation of Signal Transducers and Activators of Transcription 3 and Focal Adhesion Kinase by Stromal Cell‐Derived Factor 1 Is Required for Migration of Human Mesenchymal Stem Cells in Response to Tumor Cell‐Conditioned Medium , 2009, Stem cells.

[67]  B. Badran,et al.  Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. , 2013, World journal of stem cells.

[68]  J. Hinshaw.  Dynamin and Its Role in Membrane Fission , 2022 .

[69]  T. Kubo,et al.  Osteoporosis influences the late period of fracture healing in a rat model prepared by ovariectomy and low calcium diet , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[70]  A. Harris,et al.  Novel Mechanism of Action for Hydralazine: Induction of Hypoxia-Inducible Factor-1 &agr;, Vascular Endothelial Growth Factor, and Angiogenesis by Inhibition of Prolyl Hydroxylases , 2004, Circulation research.

[71]  Harry Rakowski,et al.  Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. , 2011, European heart journal.

[72]  Jin Han,et al.  Stimulation of chondrogenic differentiation of mesenchymal stem cells. , 2012, International journal of stem cells.

[73]  Ryosuke Ozasa,et al.  Construction of human induced pluripotent stem cell‐derived oriented bone matrix microstructure by using in vitro engineered anisotropic culture model , 2017, Journal of biomedical materials research. Part A.

[74]  E. Lee,et al.  Transcriptional regulatory cascades in Runx2-dependent bone development. , 2013, Tissue engineering. Part B, Reviews.

[75]  Jiang Peng,et al.  Role of mesenchymal stem cells in bone regeneration and fracture repair: a review , 2013, International Orthopaedics.

[76]  D. Xue,et al.  Signaling pathways involved in the effects of HMGB1 on mesenchymal stem cell migration and osteoblastic differentiation. , 2016, International journal of molecular medicine.

[77]  I. Ko,et al.  Targeting improves MSC treatment of inflammatory bowel disease. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[78]  R. Zhao,et al.  The Role of Chemokines in Mesenchymal Stem Cell Homing to Myocardium , 2011, Stem Cell Reviews and Reports.

[79]  R. Henschler,et al.  Current Developments in Mobilization of Hematopoietic Stem and Progenitor Cells and Their Interaction with Niches in Bone Marrow , 2017, Transfusion Medicine and Hemotherapy.

[80]  Y. Kawakami,et al.  The role of TGFβs and Sox9 during limb chondrogenesis , 2006 .

[81]  S. Papson,et al.  “Model” , 1981 .

[82]  Eric J Topol,et al.  Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy , 2003, The Lancet.

[83]  A. Kriegel,et al.  Hypoxic Preconditioning with Cobalt of Bone Marrow Mesenchymal Stem Cells Improves Cell Migration and Enhances Therapy for Treatment of Ischemic Acute Kidney Injury , 2013, PloS one.

[84]  Seung Hoon Lee,et al.  Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis , 2016, Scientific Reports.

[85]  Yan Huang,et al.  Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.

[86]  M. Barbosa,et al.  Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials , 2012, Journal of the Royal Society Interface.

[87]  A. de Becker,et al.  Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? , 2016, World journal of stem cells.

[88]  M. McNiven,et al.  Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1. , 2013, Developmental cell.

[89]  S. Koh,et al.  Direct GSK-3β Inhibition Enhances Mesenchymal Stromal Cell Migration by Increasing Expression of Beta-PIX and CXCR4 , 2013, Molecular Neurobiology.

[90]  M. Ashraf,et al.  Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling. , 2009, American journal of physiology. Heart and circulatory physiology.

[91]  K. Bessho,et al.  Pluripotency of mesenchymal cells derived from synovial fluid in patients with temporomandibular joint disorder. , 2011, Life sciences.

[92]  Y. Mishina,et al.  PDGF-AA Promotes Osteogenic Differentiation and Migration of Mesenchymal Stem Cell by Down-Regulating PDGFRα and Derepressing BMP-Smad1/5/8 Signaling , 2014, PloS one.

[93]  Juan Du,et al.  Local application of IGFBP5 protein enhanced periodontal tissue regeneration via increasing the migration, cell proliferation and osteo/dentinogenic differentiation of mesenchymal stem cells in an inflammatory niche , 2017, Stem Cell Research & Therapy.

[94]  W. Xue,et al.  Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs. , 2010, Biochemical and biophysical research communications.

[95]  Liming Bian,et al.  Enhanced MSC chondrogenesis following delivery of TGF-β3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. , 2011, Biomaterials.

[96]  Liangliang Xu,et al.  Sox11‐modified mesenchymal stem cells (MSCs) accelerate bone fracture healing: Sox11 regulates differentiation and migration of MSCs , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[97]  Z. Madeja,et al.  Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. , 2011, Experimental hematology.